In Q2FY16, total revenues of Alembic Pharmaceuticals increased by 84.4% YoY to Rs 10.1 bn (our estimates Rs 10.8 bn) compared to Rs 5.5 bn in Q2FY15, due to higher export formulations sales on account of revenues generated from Abilify opportunity.